<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03616119</url>
  </required_header>
  <id_info>
    <org_study_id>QastroHep</org_study_id>
    <nct_id>NCT03616119</nct_id>
  </id_info>
  <brief_title>Gastroesophageal Reflux Disease in Azerbaijan</brief_title>
  <official_title>The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sevda Aghayeva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azerbaijan Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azerbaijan Gastroenterology and Hepatology Association</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended
      to evaluate the prevalence of the disease in the regions as well as the capital by cluster
      sampling ,ethitology and to compare the outcomes depending on the geographical location.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is an observational, nationwide study. The GERD questionnaire (1994) requested from Mayo
      clinic, was received and validated. The questionnaire was translated by 3 individuals from
      english to azeri and back trasnlated by 3 native english speakers.

      Power analysis was performed. The research was presented for the approval to Ethical
      Committee of Azerbaijan Medical University.

      Prior to the actual study, a pilot study with smaller number of participants was performed
      and the results were evaluated.

      Cluster sampling methodology was provided by the statistical department of Azerbaijan Medical
      University.

      110 employees were hired for using a survey in different regions of Azerbaijan. Written
      consent was obtained from every person evaluated. Statistical ananlysis was performed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>GER questionnaire (GERQ) of Mayo case 1998- 019</measure>
    <time_frame>1 year</time_frame>
    <description>Observational study</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Azerbaijan is divided by clusters with a definite numbers of individuals to take survey on
        reflux disease in the given age range and calculated by proportion of males and females.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18-80

          -  Both genders

          -  Hearburn

          -  Belching

          -  Regurgitation

        Exclusion Criteria:

          -  protom pomp inhibitor use

          -  antibiotic use in the last 4 weeks

          -  upper GI surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>18-80 age range</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sevda Aghayeva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azerbaijan Gastroenterology and Hepatology Association</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azerbaijan Gastroenterology and hepatology Association</name>
      <address>
        <city>Baku</city>
        <state>Nasimi</state>
        <zip>AZ1018</zip>
        <country>Azerbaijan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Azerbaijan</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Azerbaijan Gastroenterology and Hepatology Association</investigator_affiliation>
    <investigator_full_name>Sevda Aghayeva</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>gastoesophageal reflux disease</keyword>
  <keyword>prevalence</keyword>
  <keyword>Azerbaijan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

